GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...

The safety review was requested by the French medicines agency, citing new safety reports that alter the risk profile of ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Mpox – formerly known as monkeypox – is rapidly spreading in several African countries, prompting the World Health ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

Siyuan Chen, general manager for Bristol Myers Squibb in China and Asia, decided to climb Mount Kilimanjaro in Tanzania with ...

Underestimating the importance of this role could make or break your operating model transformation: here’s how to think about sourcing the role that will only increase in importance.

The Global Drug Device Combination Products Market is projected to reach USD 174.4 billion in 2024 which is further ...

Rocky Brands operates in the footwear market with multiple brands but struggles with financial stability. Find out why I ...

Exosomes, spicules, and peptides—in a healthcare-inspired formulation—out-performs retinol in independent studies, Modern Molecules says.

Invest in IDRV ETF for exposure to the global self-driving EV market, focusing on EV and tech sectors with high growth ...